Emerging echinocandins for treatment of invasive fungal infections

Expert Opinion on Emerging Drugs
Michelle S TurnerJohn R Perfect

Abstract

The echinocandins are a new class of antifungals, developed in response to the need for safe and effective antifungals for the treatment of invasive fungal infections. These agents work by inhibiting 1,3-beta-d-glucan synthase, an enzyme essential for production of cell walls in select fungi. Echinocandins appear to demonstrate favourable activity in vitro against a variety of yeasts (including both Candida albicans and non-albicans Candida) as well as select moulds (including Aspergillus spp.) In general, all echninocandins demonstrate a favourable safety profile and require once-daily parenteral administration. Caspofungin is the first of these agents to be available in the US, and is approved for empirical antifungal therapy in febrile neutropenic patients, candidaemia and select forms of invasive candidiasis, and for management of invasive aspergillosis in patients refractory to or intolerant of other therapies. Micafungin was recently approved by the FDA for treatment of oesophageal candidiasis, and for the prophylaxis of fungal infections in haematopoietic stem cell transplant recipients. Emerging data indicate micafungin may have an important role in the treatment of invasive forms of candidiasis. Anidulafungin is an ech...Continue Reading

References

Mar 1, 1990·Reviews of Infectious Diseases·H A GallisW W Pickard
Dec 1, 1988·Archives of Internal Medicine·S B WeyR P Wenzel
Jan 27, 1994·The New England Journal of Medicine·J A Como, W E Dismukes
Jul 1, 1995·The Journal of Antimicrobial Chemotherapy·G St-GermainL de Repentigny
Jan 1, 1996·Mycoses·E SpeeleveldC Raes-Wuytack
Nov 1, 1996·Diagnostic Microbiology and Infectious Disease·M E ErnstM A Pfaller
Nov 26, 1997·Antimicrobial Agents and Chemotherapy·K BartizalJ Balkovec
Nov 26, 1997·Antimicrobial Agents and Chemotherapy·R HajduH Kropp
Aug 4, 1998·Antimicrobial Agents and Chemotherapy·M A PowlesD Schmatz
Aug 26, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M H WhiteC B Miller
Oct 3, 1998·Antimicrobial Agents and Chemotherapy·A S OrozcoS G Filler
Dec 10, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J R WingardJ Lister
Feb 2, 2000·World Journal of Urology·J D Sobel, J A Vazquez
Sep 12, 2000·The Journal of Antimicrobial Chemotherapy·H MikamoT Tamaya
Jan 12, 2001·Journal of Chemotherapy·V Fanos, L Cataldi
Mar 7, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D W BatesR Platt
Apr 17, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J W BaddleyP G Pappas
Jun 26, 2001·Journal of Clinical Pharmacy and Therapeutics·L WillemsK de Beule
Aug 7, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M M McNeilD W Warnock
Oct 6, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A VillanuevaC A Sable
Dec 26, 2001·Antimicrobial Agents and Chemotherapy·Sevtap ArikanJohn H Rex
Jan 25, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·David W DenningHartmut Lode
Jan 30, 2002·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Linda R LumJohn Leone
Feb 19, 2002·Antimicrobial Agents and Chemotherapy·Julie A StoneScott A Waldman
Mar 7, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Kieren A MarrLawrence Corey

❮ Previous
Next ❯

Citations

Apr 1, 2008·Eukaryotic Cell·Leah E Cowen, William J Steinbach
Oct 12, 2007·Paediatric Drugs·Benito Almirante, Dolors Rodríguez
Dec 17, 2008·Future Microbiology·Pola de la TorreAnnette C Reboli
Sep 7, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Peter G PappasDonald N Buell
Feb 3, 2007·Expert Review of Anti-infective Therapy·Pola de la Torre, Annette C Reboli
Oct 31, 2009·Expert Opinion on Therapeutic Patents·Pore Vandana SudhirAher Nilkanth Ganpat
Jul 23, 2009·Expert Review of Anti-infective Therapy·M Anaul Kabir, Mohammad Asif Hussain
Sep 30, 2008·Journal of Enzyme Inhibition and Medicinal Chemistry·Francis ChevreuilPascal Richomme
Nov 27, 2007·Journal of Enzyme Inhibition and Medicinal Chemistry·Francis ChevreuilPascal Richomme
Feb 6, 2009·Current Medical Research and Opinion·Sheenu ChandwaniThomas F Patterson
Sep 6, 2011·European Journal of Medicinal Chemistry·Bhuwan B Mishra, Vinod K Tiwari
Oct 12, 2010·The Veterinary Clinics of North America. Small Animal Practice·Daniel S Foy, Lauren A Trepanier
Apr 20, 2010·International Journal of Antimicrobial Agents·Suganthini Krishnan-NatesanPranatharthi H Chandrasekar
Sep 25, 2007·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·D LagoutteP M Loiseau
Jul 21, 2015·Annals of the New York Academy of Sciences·David S Perlin
Jun 14, 2006·Journal of Mass Spectrometry : JMS·Alexandr JegorovVladimir Havlicek
Jul 27, 2010·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Jan HeeresPaul Lewi
Dec 13, 2012·Annals of the New York Academy of Sciences·George DimopoulosApostolos Armaganidis
Jul 3, 2021·International Journal of Molecular Sciences·Danish KhanVytas A Bankaitis

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aspergillosis

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Aspergillosis (ASM)

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

The New England Journal of Medicine
J D Sobel, Sanjay G Revankar
Expert Opinion on Investigational Drugs
George Aperis, Eleftherios Mylonakis
Mycoses
Oliver A CornelySabine Aisenbrey
© 2022 Meta ULC. All rights reserved